The dialogue emphasises the need for better communication between patients and healthcare providers, the role of technology in improving diagnosis and treatment, and the significance of advocacy and awareness in the PAH community. The discussion concludes with a call for collaboration between patients, healthcare professionals, and pharmaceutical companies to enhance the quality of life for those affected by PAH.
Listen or download our podcast on the last Thursday of every month on all podcast channels.
Brought to you by electronRx
Follow us on LinkedIn
